• Mashup Score: 1

    Use of postnatal selective serotonin reuptake inhibitors was associated with reduced risks for maternal depression and unfavorable outcomes associated with postnatal depression, researchers reported in JAMA Network Open.“Data from primary care records in the U.K. have indicated that the prevalence of postnatal depression is 11%, whereas the initiation rate of selective serotonin reuptake

    Tweet Tweets with this article
    • Use of postnatal #SSRIs was associated with reduced risks for maternal #depression and unfavorable outcomes associated with postnatal depression, researchers reported in @JAMANetworkOpen. Learn more. https://t.co/xL28DaW9WL

  • Mashup Score: 0

    Although some of the data remain incomplete, in 2022, patients will continue to make individual decisions factoring in the effect of maternal adversity in a more deliberate way and with a refined lens through with which to see their options with respect to using or not using SSRIs during pregnancy.

    Tweet Tweets with this article
    • Concern about the effects of fetal exposure to #SSRIs is appropriate given the consistent data that approximately 7% of women use #antidepressants during pregnancy. https://t.co/YucFUwiC6S https://t.co/tpDz5rGTS8

  • Mashup Score: 6

    Although some of the data remain incomplete, in 2022, patients will continue to make individual decisions factoring in the effect of maternal adversity in a more deliberate way and with a refined lens through with which to see their options with respect to using or not using SSRIs during pregnancy.

    Tweet Tweets with this article
    • Concern about the effects of fetal exposure to #SSRIs is appropriate given the consistent data that approximately 7% of women use #antidepressants during pregnancy. https://t.co/9mSPDR6VOd https://t.co/gb1xuIGNWW